Seeking Alpha
  • Michael Bryant
    Despite Monday's 26% surge, Keryx Biopharmaceuticals (KERX) is still way off its high a month ago.
    Reply (1)
    • iadops40: KERX will hit it this time with Zerenex, not as big of a market value as was leading up w/ failed Perifosine. It will make a run, $3-4 imo